The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE)
- 1 December 2012
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 130 (6), 914-918
- https://doi.org/10.1016/j.thromres.2012.06.008
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous ThromboembolismClinical and Applied Thrombosis/hemostasis, 2009
- Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosisThrombosis and Haemostasis, 2007
- Antiphospholipid antibody tests: spreading the netAnnals Of The Rheumatic Diseases, 2005
- Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid‐to‐late pregnancy loss*Journal of Obstetrics and Gynaecology Research, 2004
- Antiphospholipid and Antiprotein Syndromes in Non-thrombotic, Non-autoimmune Women with Unexplained Recurrent Primary Early Foetal LossThrombosis and Haemostasis, 2000
- Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy lossesFertility and Sterility, 1999
- Antiphosphatidylethanolamine Antibodies in Systemic Lupus ErythematosusLupus, 1993
- Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis.Annals Of The Rheumatic Diseases, 1989
- Association of lupus anticoagulant with antibody against phosphatidylserineClinical Immunology and Immunopathology, 1987
- Membrane and lipid involvement in blood coagulationBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1978